|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Pozen%2C+Inc.+%28POZN%29+Reports+In-Line+Q1+Loss+of+19cShare/8315816.html for the full story.
Benzinga
Apr 5
Comment
Uroplasty (NASDAQ: UPI) shares touched a new 52-week low of $2.28. Uroplasty announced the resignation of its CEO.
Silicon Motion Technology (NASDAQ: SIMO) shares reached a new 52-week low of $10.50. Silicon Motion shares have dropped 42.01%...
StreetInsider.com
Mar 27
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/POZEN+Inc.+%28POZN%29+Submits+PA32540PA8140+NDA+to+FDA+for+Marketing+Approval/8213786.html for the full story.
Benzinga
Mar 6
Comment
In a report published Wednesday, Zacks reiterated its Outperform rating and $9.50 price target on POZEN (NASDAQ: POZN).
Zacks noted, “The phase 3 clinical data on Pozen s PA-325/40 product has been presented now at three high-profile medical...
Benzinga
Feb 8
Comment
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming
medicine that transforms lives, presented data today from the combined results
of two Phase 3 studies of PA32540, an antiplatelet therapy of enteric-coated
(EC) and...
Forbes
Feb 6
Comment
In his book, Extreme Productivity: Boost Your Results, Reduce Your Hours, Harvard Business School Senior Lecturer Robert Pozen shares performance-enhancing tips on everything from better sleep on overnight business flights to dealing with...
Benzinga
Nov 9
Comment
In a report published Friday, Ascendiant Capital Markets upgraded its rating on POZEN (NASDAQ: POZN) to Strong Buy, and reiterated its $8.25 price target.
Ascendiant Capital noted, “We believe that the focus for investors should remain on the...
StreetInsider.com
Nov 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Pozen%2C+Inc.+%28POZN%29+Misses+Q3+EPS+by+4c/7856767.html for the full story.
Clusterstock
Oct 22
Comment
According to Harvard Lecturer Robert Pozen, most people get productivity all wrong. We put too much emphasis on hours worked and not enough on quality.
In his new book, "Extreme Productivity," Pozen gives some excellent tips on how to maximize...
Benzinga
Aug 29
Comment
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced the presentation
of Phase 1 data, at the European Society of Cardiologists 2012 Congress,
from a study of...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
